quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·106d
PRRelease
Purple Biotech Ltd. logo

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

PPBT· Purple Biotech Ltd.
Health Care
Original source

Companies

  • PPBT
    Purple Biotech Ltd.
    Health Care

Related

  • SEC1d
    SEC Form 6-K filed by Purple Biotech Ltd.
  • PR1d
    Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform
  • INSIDER6d
    SEC Form 3 filed by new insider Rock Simcha
  • INSIDER16d
    SEC Form 3 filed by new insider Zilberberg Suzana
  • INSIDER17d
    SEC Form 3 filed by new insider Agmon Ido
  • INSIDER24d
    SEC Form 3 filed by new insider Efron Gil
  • INSIDER24d
    Amendment: SEC Form 3 filed by new insider Lankry Shai S
  • INSIDER24d
    SEC Form 3 filed by new insider Schickler Michael
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022